Scholarlink

Purpose <p>Health-related quality of life (HRQoL) data among patients with breast cancer (BC) in Malaysia remain limited. This study aimed to describe HRQoL and identify its key predictors to inform future health policy planning.</p> Methods <p>A cross-sectional survey was conducted between April 2023 and January 2025 among BC outpatients in eight public specialist hospitals in Malaysia. Sociodemographic and clinical data were collected alongside patient-reported outcome measures, including the EuroQol-5 Dimension 5-Level questionnaire (EQ-5D-5L), a preference-based health utility measure, and the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30), a cancer-specific HRQoL questionnaire. Multivariable linear regression models were used to identify independent predictors of HRQoL for each instrument.</p> Results <p>The mean (standard deviation) EQ-5D-5L health state utility value (HSUV) was 0.853 (0.179), the mean EQ-VAS score was 79.2 (19.1), and the mean (standard deviation) EORTC QLQ-C30 summary score was 83.3 (15.3). The EQ-5D-5L dimensions with the highest prevalence of reported problems were pain/discomfort and anxiety/depression. The EQ-5D-5L HSUV and VAS score demonstrated moderate to strong positive correlations with the EORTC QLQ-C30 summary score (ρ = 0.503 to 0.672, <i>p</i> &lt; 0.001). In multivariable analysis, advanced cancer stage, Chinese ethnicity, and lower education were independently associated with poorer EQ-5D-5L HSUV. EQ-VAS scores were associated with Indian ethnicity and completion of the questionnaire in English. For EORTC QLQ-C30, advanced cancer stages and Chinese ethnicity remained significant predictors.</p> Conclusion <p>HRQoL among patients with BC in Malaysia was primarily influenced by cancer stage, ethnicity, and education level. Advanced cancer stage was consistently associated with poorer patient-reported outcomes. The complementary use of EQ-5D-5L and EORTC QLQ-C30 provides more comprehensive estimates to inform survivorship care and future economic evaluations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Health related quality of life of patients with breast cancer in Malaysia: evidence from EQ-5D-5L and EORTC QLQ-C30

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月23日

查看全文
  • Siew Chin Ong,
  • Sook Pin Goh,
  • Siew Wei Yeong,
  • Chow Kyn Ng,
  • Yi Jing Tan,
  • Muhammad Daoud Butt,
  • Kian Keong Kong,
  • Sin Dee Cheah,
  • Boon Seang Tan,
  • Jen Ven Lee,
  • Ros Suzanna Ahmad Bustamam,
  • Wei Wern Khor,
  • Liyana Ahamad Fouzi,
  • Aina Shafiza Abd Aziz,
  • Su Yiu Chieng,
  • Sarahfarina Abd Rahim

摘要

Purpose

Health-related quality of life (HRQoL) data among patients with breast cancer (BC) in Malaysia remain limited. This study aimed to describe HRQoL and identify its key predictors to inform future health policy planning.

Methods

A cross-sectional survey was conducted between April 2023 and January 2025 among BC outpatients in eight public specialist hospitals in Malaysia. Sociodemographic and clinical data were collected alongside patient-reported outcome measures, including the EuroQol-5 Dimension 5-Level questionnaire (EQ-5D-5L), a preference-based health utility measure, and the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30), a cancer-specific HRQoL questionnaire. Multivariable linear regression models were used to identify independent predictors of HRQoL for each instrument.

Results

The mean (standard deviation) EQ-5D-5L health state utility value (HSUV) was 0.853 (0.179), the mean EQ-VAS score was 79.2 (19.1), and the mean (standard deviation) EORTC QLQ-C30 summary score was 83.3 (15.3). The EQ-5D-5L dimensions with the highest prevalence of reported problems were pain/discomfort and anxiety/depression. The EQ-5D-5L HSUV and VAS score demonstrated moderate to strong positive correlations with the EORTC QLQ-C30 summary score (ρ = 0.503 to 0.672, p < 0.001). In multivariable analysis, advanced cancer stage, Chinese ethnicity, and lower education were independently associated with poorer EQ-5D-5L HSUV. EQ-VAS scores were associated with Indian ethnicity and completion of the questionnaire in English. For EORTC QLQ-C30, advanced cancer stages and Chinese ethnicity remained significant predictors.

Conclusion

HRQoL among patients with BC in Malaysia was primarily influenced by cancer stage, ethnicity, and education level. Advanced cancer stage was consistently associated with poorer patient-reported outcomes. The complementary use of EQ-5D-5L and EORTC QLQ-C30 provides more comprehensive estimates to inform survivorship care and future economic evaluations.